BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37012662)

  • 1. PU.1 is a useful nuclear marker to distinguish between histiocytosis and histiocyte-rich tumours.
    Ungureanu IA; Cohen-Aubart F; Héritier S; Haroche J; Donadieu J; Emile JF
    Histopathology; 2023 Aug; 83(2):320-325. PubMed ID: 37012662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OCT2 expression in histiocytoses.
    Ungureanu IA; Cohen-Aubart F; Héritier S; Fraitag S; Charlotte F; Lequain H; Hélias-Rodzewicz Z; Haroche J; Donadieu J; Emile JF
    Virchows Arch; 2023 Jul; 483(1):81-86. PubMed ID: 36754897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of neuroimaging features of histiocytic neoplasms with central nervous system involvement: a retrospective study of 121 adult patients.
    Fan X; Liu T; Zhang Z; Sun J; Niu N; Mao C; Wang F; Li J; Zhou D; Cao X; Jin Z; Feng F
    Eur Radiol; 2023 Nov; 33(11):8031-8042. PubMed ID: 37191919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1.
    Gatalica Z; Bilalovic N; Palazzo JP; Bender RP; Swensen J; Millis SZ; Vranic S; Von Hoff D; Arceci RJ
    Oncotarget; 2015 Aug; 6(23):19819-25. PubMed ID: 26110571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strong Coexpression of Transcription Factors PU.1 and Oct-2 in Rosai-Dorfman Disease.
    Kiruthiga KG; Younes S; Natkunam Y
    Am J Clin Pathol; 2022 Dec; 158(6):672-677. PubMed ID: 36239684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.
    Papo M; Cohen-Aubart F; Trefond L; Bauvois A; Amoura Z; Emile JF; Haroche J
    Curr Oncol Rep; 2019 May; 21(7):62. PubMed ID: 31115724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAP2K1-driven mixed Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease and Erdheim-Chester disease, clonally related to acute myeloid leukemia.
    Bonometti A; Ferrario G; Parafioriti A; Giardino D; Simonetti F; Ginori A; Passoni E; Berti E;
    J Cutan Pathol; 2021 May; 48(5):637-643. PubMed ID: 33188581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How I Diagnose Rosai-Dorfman Disease.
    Ravindran A; Rech KL
    Am J Clin Pathol; 2023 Jul; 160(1):1-10. PubMed ID: 37167084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathologic analysis of extranodal Rosai-Dorfman disease of breast: a report of 12 cases].
    Chen YP; Jiang XN; Lu JP; Zhang H; Li XQ; Chen G
    Zhonghua Bing Li Xue Za Zhi; 2016 Aug; 45(8):556-60. PubMed ID: 27510782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histiocytic disorders of the gastrointestinal tract.
    Detlefsen S; Fagerberg CR; Ousager LB; Lindebjerg J; Marcussen N; Nathan T; Sørensen FB
    Hum Pathol; 2013 May; 44(5):683-96. PubMed ID: 23063502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histiocytic diseases in childhood and adolescence].
    Vokuhl C; Oschlies I; Klapper W; Leuschner I
    Pathologe; 2015 Sep; 36(5):443-50. PubMed ID: 26292932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changing landscape of pediatric histiocytoses: Birth, life, and transdifferentiation of pediatric histiocytes.
    Auerbach A; Aguilera NS
    Semin Diagn Pathol; 2023 Nov; 40(6):420-428. PubMed ID: 37258365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Erdheim-Chester disease and Rosai-Dorfman disease: Pathological, radiological and clinical features of adult non-Langerhans cell histiocytosis].
    Bösmüller H; Nann D; Horger M; Fend F
    Pathologe; 2015 Sep; 36(5):458-66. PubMed ID: 26305142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary histiocytosis: beyond Langerhans cell histiocytosis related to smoking.
    Gallego CT; Bueno J; Cruces E; Stelow EB; Mancheño N; Flors L
    Radiologia (Engl Ed); 2019; 61(3):215-224. PubMed ID: 30686482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The histiocytoses: clinical presentation and differential diagnosis.
    Gonzalez CL; Jaffe ES
    Oncology (Williston Park); 1990 Nov; 4(11):47-60; discussion 60, 62. PubMed ID: 2150325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CNS Erdheim-Chester Disease: A Challenge to Diagnose.
    Pan Z; Kleinschmidt-DeMasters BK
    J Neuropathol Exp Neurol; 2017 Dec; 76(12):986-996. PubMed ID: 29096034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological Manifestations of Histiocytic Disorders.
    Banks SA; Sartori Valinotti JC; Go RS; Abeykoon JP; Goyal G; Young JR; Koster MJ; Vassallo R; Ryu JH; Davidge-Pitts CJ; Ravindran A; Bennani NN; Shah MV; Rech KL; Tobin WO;
    Curr Neurol Neurosci Rep; 2023 Jun; 23(6):277-286. PubMed ID: 37209319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in the Histopathologic Diagnosis of Histiocytic Neoplasms.
    Rech KL; He R
    J Natl Compr Canc Netw; 2021 Nov; 19(11):1305-1311. PubMed ID: 34781270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Langerhans cell histiocytosis with isolated CNS involvement: an unusual variant of Erdheim-Chester disease.
    Conley A; Manjila S; Guan H; Guthikonda M; Kupsky WJ; Mittal S
    Neuropathology; 2010 Dec; 30(6):634-47. PubMed ID: 20337948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emperipolesis in the cerebrospinal fluid from a patient with Rosai-Dorfman disease.
    Kraeft SK; Honig M; Krishnamurthy S
    Diagn Cytopathol; 2008 Jan; 36(1):67-8. PubMed ID: 18064697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.